Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Biofunctional Materials is Scopus-indexed (Q4, CiteScore 0.7), DOAJ. Published by ELSP.
Checked against the index lists dated .
ISSN 2959-0574Verify ISSN ↗2959-0582Verify ISSN ↗
Publisher: ELSP
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 151 / 191 | 21st | Q4 |
| Artificial Intelligence | 456 / 570 | 20th | Q4 |
| Biotechnology | 292 / 325 | 10th | Q4 |
| Biomedical Engineering | 309 / 342 | 9th | Q4 |
| Biomaterials | 134 / 146 | 8th | Q4 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2024–present, best quartile Q4, CiteScore 0.7.
Biofunctional Materials is Q4 in Pharmaceutical Science (rank 151 of 191), Q4 in Artificial Intelligence (rank 456 of 570) and Q4 in Biotechnology (rank 292 of 325), by CiteScore 2025. It is ranked in 5 subject areas in all.
Biofunctional Materials is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 0.7, quartile Q4, 21st percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric.
Biofunctional Materials is published by ELSP. Its print ISSN is 2959-0574 and its online ISSN is 2959-0582.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Biofunctional Materials has an h-index of 3 and a 2-year mean of 0.6 citations per paper (OpenAlex). Its Scopus CiteScore is 0.7, quartile Q4. On 2-year citations it ranks #128 of 177 Scopus journals in Pharmaceutical Science.
Biofunctional Materials published 18 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 41 research articles (2022–2026), authors are most often from China (32.9%), India (14.6%) and United States (13.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.